Primary Site >> Colorectal Cancer
Gene >> FCGR2A
| 1. | |||||||||||
| Journal: | Cancer Immunol Immunother. 1992;35(3):158-64. | ||||||||||
| Title: | Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor. | ||||||||||
| Author: | Ragnhammar, P|Masucci, G|Frodin, J E|Hjelm, A L|Mellstedt, H | ||||||||||
| PMID: | 1638551 | ||||||||||
| 2. | |||||||||||
| Journal: | Int J Immunopharmacol. 1997 Aug;19(8):413-20. | ||||||||||
| Title: | Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients. | ||||||||||
| Author: | Heidecke, H|Eckert, K|Schulze-Forster, K|Maurer, H R | ||||||||||
| PMID: | 9568546 | ||||||||||
| 3. | |||||||||||
| Journal: | Ann Oncol. 1998 Apr;9(4):453-5. | ||||||||||
| Title: | Irinotecan-induced immune thrombocytopenia. | ||||||||||
| Author: | Bozec, L|Bierling, P|Fromont, P|Levi, F|Debat, P|Cvitkovic, E|Misset, J L | ||||||||||
| PMID: | 9636839 | ||||||||||
| 4. | |||||||||||
| Journal: | J Thromb Haemost. 2009 Jan;7(1):171-81. | ||||||||||
| Title: | Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. | ||||||||||
| Author: | Meyer, T|Robles-Carrillo, L|Robson, T|Langer, F|Desai, H|Davila, M|Amaya, M|Francis, J L|Amirkhosravi, A | ||||||||||
| PMID: | 18983497 | ||||||||||
| 5. | |||||||||||
| Journal: | BMC Cancer. 2011 Nov 25;11:496. | ||||||||||
| Title: | Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer. | ||||||||||
| Author: | Dahan, Laetitia|Norguet, Emmanuelle|Etienne-Grimaldi, Marie-Christine|Formento, Jean-Louis|Gasmi, Mohamed|Nanni, Isabelle|Gaudart, Jean|Garcia, Stephane|Ouafik, L'Houcine|Seitz, Jean-Francois|Milano, Gerard | ||||||||||
| PMID: | 22117530 | ||||||||||
| 6. | |||||||||||
| Journal: | Br J Clin Pharmacol. 2012 May;73(5):776-85. | ||||||||||
| Title: | Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan. | ||||||||||
| Author: | Etienne-Grimaldi, Marie-Christine|Bennouna, Jaafar|Formento, Jean-Louis|Douillard, Jean-Yves|Francoual, Mireille|Hennebelle, Isabelle|Chatelut, Etienne|Francois, Eric|Faroux, Roger|El Hannani, Chaza|Jacob, Jacques-Henri|Milano, Gerard | ||||||||||
| PMID: | 22486600 | ||||||||||
| 7. | |||||||||||
| Journal: | Anticancer Res. 2013 Nov;33(11):4995-8. | ||||||||||
| Title: | Predicting skin toxicity according to EGFR polymorphisms in patients with colorectal cancer receiving antibody against EGFR. | ||||||||||
| Author: | Saito, Rie|Suzuki, Hideo|Yamada, Takeshi|Endo, Shinji|Moriwaki, Toshikazu|Ueno, Takunori|Hirose, Mitsuaki|Hirai, Sachiko|Yamato, Kenji|Mizokami, Yuji|Hyodo, Ichinosuke | ||||||||||
| PMID: | 24222141 | ||||||||||
| 8. | |||||||||||
| Journal: | Clin Cancer Res. 2016 May 15;22(10):2435-44. | ||||||||||
| Title: | Fc-gamma Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer. | ||||||||||
| Author: | Liu, Geoffrey|Tu, Dongsheng|Lewis, Marcia|Cheng, Dangxiao|Sullivan, Leslie A|Chen, Zhuo|Morgen, Eric|Simes, John|Price, Timothy J|Tebbutt, Niall C|Shapiro, Jeremy D|Jeffery, G Mark|Mellor, J Daniel|Mikeska, Thomas|Virk, Shakeel|Shepherd, Lois E|Jonker, De | ||||||||||
| PMID: | 27179112 | ||||||||||
| 9. | |||||||||||
| Journal: | Clin Cancer Res. 2016 Oct 1;22(19):4958. | ||||||||||
| Title: | FCGR, Cetuximab, and Colorectal Cancer Survival-Letter. | ||||||||||
| Author: | Negri, Francesca V|Boggiani, Daniela|Rimanti, Anita|Musolino, Antonino | ||||||||||
| PMID: | 27697992 | ||||||||||
| 10. | |||||||||||
| Journal: | Pharmacogenomics J. 2017 Dec;17(6):535-542. | ||||||||||
| Title: | Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. | ||||||||||
| Author: | Morgen, E K|Lenz, H-J|Jonker, D J|Tu, D|Milano, G|Graziano, F|Zalcberg, J|Karapetis, C S|Dobrovic, A|O'Callaghan, C J|Liu, G | ||||||||||
| PMID: | 27897268 | ||||||||||
| 11. | |||||||||||
| Journal: | Clin Transl Oncol. 2017 Aug;19(8):1018-1027. | ||||||||||
| Title: | Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis. | ||||||||||
| Author: | Li, H|Jin, Z|Li, X|Wu, L|Jin, J | ||||||||||
| PMID: | 28243990 | ||||||||||
| 12. | |||||||||||
| Journal: | Pharmacogenomics J. 2018 May 22;18(3):474-479. | ||||||||||
| Title: | The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab. | ||||||||||
| Author: | Magnes, T|Melchardt, T|Hufnagl, C|Weiss, L|Mittermair, C|Neureiter, D|Klieser, E|Rinnerthaler, G|Roesch, S|Gaggl, A|Greil, R|Egle, A | ||||||||||
| PMID: | 28719596 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Med. 2018 Oct 14. | ||||||||||
| Title: | Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. | ||||||||||
| Author: | Shepshelovich, Daniel|Townsend, Amanda R|Espin-Garcia, Osvaldo|Latifovic, Lidija|O'Callaghan, Chris J|Jonker, Derek J|Tu, Dongsheng|Chen, Eric|Morgen, Eric|Price, Timothy J|Shapiro, Jeremy|Siu, Lillian L|Kubo, Michiaki|Dobrovic, Alexander|Ratain, Mark J|X | ||||||||||
| PMID: | 30318772 | ||||||||||